DOSSIER · 13F Holders · Q2 2026
Lyell Immunopharma, Inc.
2 institutions still hold Lyell Immunopharma, Inc. as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 55083R104·2 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
2 institutions reported Lyell Immunopharma, Inc. in Q2 2026. Decheng Capital LLC leads at 91.6% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.